Evigrade
Moderate

Budesonide × Ibuprofen

Inhaled corticosteroids (ICS)×Non-steroidal anti-inflammatory drugs (NSAIDs)

Mechanism

Additive GI ulcer and bleeding risk with systemic budesonide. Inhaled budesonide does not clinically affect risk.

Symptoms

Epigastric pain, heartburn, black or tarry stools, blood in vomit, bruising. Higher risk in older patients, prior peptic ulcer, and concurrent anticoagulants.

Management

On systemic budesonide, limit ibuprofen to short courses (no more than 5–7 days) with pantoprazole 20 mg/day. For long-term analgesia: paracetamol up to 2 g/day. Inhaled budesonide with ibuprofen is safe. In older patients and prior peptic ulcer, risk outweighs benefit — consider paracetamol or topical NSAIDs.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Sources

All interactions